Cargando…
The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus
BACKGROUND: In the absence of effective drugs, controlling SARS relies on the rapid identification of cases and appropriate management of the close contacts, or effective vaccines for SARS. Therefore, developing specific and sensitive laboratory tests for SARS as well as effective vaccines are neces...
Autores principales: | Mu, Feng, Niu, Dongsheng, Mu, Jingsong, He, Bo, Han, Weiguo, Fan, Baoxing, Huang, Shengyong, Qiu, Yan, You, Bo, Chen, Weijun |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2613400/ https://www.ncbi.nlm.nih.gov/pubmed/19038059 http://dx.doi.org/10.1186/1471-2180-8-207 |
Ejemplares similares
-
Real-Time Quantitative Fluorescent Reverse Transcriptase-PCR for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus RNA
por: Chen, Weijun, et al.
Publicado: (2012) -
Recombinant highly antigenic truncated fusion-based protein as a diagnostic antigen for anti-SARS-CoV-2 nucleocapsid antibody ELISA
por: Salarifar, Abbasali, et al.
Publicado: (2023) -
Development of an immunochromatography strip test based on truncated nucleocapsid antigens of three representative hantaviruses
por: Amada, Takako, et al.
Publicado: (2014) -
Spike-based COVID-19 immunization increases antibodies to nucleocapsid antigen
por: Dobaño, Carlota, et al.
Publicado: (2022) -
Genetic and antigenic characterization of recombinant nucleocapsid proteins derived from canine coronavirus and canine respiratory coronavirus in China
por: Lu, Shuai, et al.
Publicado: (2016)